Aminopterin/methotrexate embryofetopathy
MONDO:0016004Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.
Also known as: aminopterin embryopathy syndrome, fetal aminopterin syndrome, foetal aminopterin syndrome, aminopterin fetopathy syndrome, aminopterin syndrome, fetal methotrexate syndrome, foetal methotrexate syndrome
0 clinical trials for this condition and its sub-types, 0 tagged with Aminopterin/methotrexate embryofetopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.